BNET Industries
Vaxgen Inc. (VXGN) is in the Pharma Industry
- Revenue
- Dec 31 2007
- $5.0M
- Profit
- Dec 31 2007
- ($44.1M)
- Market Cap
- Aug 27 2008
- $204.3K
Latest News and Analysis
Vaxgen Files 10-Q for First Quarter With SEC, Provides Future Burn Rate Guidance
SOUTH SAN FRANCISCO, Calif., May 14 /PRNewswire-FirstCall/ -- VaxGen, Inc. (BULLETIN BOARD: VXGN) , a biopharmaceutical company, today provided guidance on its expected monthly cash expenditures following the most recent restructuring undertaken on April 9, 2008. VaxGen expects that its average monthly cash expenditures going forward are...
Emergent BioSolutions Acquires Advanced Recombinant Protective Antigen Anthrax Vaccine Candidate and Technology
Acquisition positions Emergent to offer the U.S. Government a domestic source for an advanced anthrax vaccine candidate to meet planned procurement of 25 million doses of rPA vaccine ROCKVILLE, Md. -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has completed the acquisition of all assets and...
Aggressive Stock Alert: UDTT! April 1, 2008.
M2 PRESSWIRE-1 April 2008-Wall Street News Alert: Aggressive Stock Alert: UDTT! April 1, 2008C1994-2008 M2 COMMUNICATIONS LTD RDATE:01042008 Weston, FLA. -- Wall Street News Alert's "stocks to watch" this morning are: Universal Detection Technology (OTCBB: UDTT), Grant Life Sciences...
VaxGen Inc. Review in Progress.
M2 PRESSWIRE-28 March 2008-The Maybach Journal: VaxGen Inc. Review in ProgressC1994-2008 M2 COMMUNICATIONS LTD RDATE:28032008 MaybachFinancial.com is one of the fastest growing independent and unbiased research firms in the world. Investors wanting to know the truth about investing and...
Progressive Following on VaxGen Inc.
M2 PRESSWIRE-28 March 2008-Market Review: Progressive Following on VaxGen Inc.C1994-2008 M2 COMMUNICATIONS LTD RDATE:29032008 Streetinvesting.com has now resumed our progressive review of VaxGen Inc. (OTCBB:VXGN) as it opened up $0.03 nearing its 52 week low of $0.41 on above...
OTCPicks.com Daily Market Movers Digest Midday Report for Friday, March 28th NXPC, IDGI, BBRE, ODYC, QBIK, VXGN.
M2 PRESSWIRE-28 March 2008-OTCPicks.com: OTCPicks.com Daily Market Movers Digest Midday Report for Friday, March 28th NXPC, IDGI, BBRE, ODYC, QBIK, VXGNC1994-2008 M2 COMMUNICATIONS LTD RDATE:28032008 Our Stocks to Watch today include NeXplore Corporation (OTC: NXPC), INCA Designs Inc. (OTC:...
NanoViricides to Begin HIV Animal Trials
Harnessing New Therapeutic Opportunities as Vaccine Trial Failures Mount WEST HAVEN, Conn. -- NanoViricides, Inc. (OTC BB: NNVC.OB), announced today that preliminary animal trials of HivCide-I[TM], the Company's proposed HIV therapeutic, will begin soon at a BSL-3 facility in Boston, MA. The initial results are expected by the...
ISS Recommends Vote Against VaxGen Proposals—Applauded by MedCap
ISS Recommends Vote Against the Merger with Raven and the New Equity Incentive Plan SAN FRANCISCO -- MedCap Management & Research LLC and its affiliates ("MedCap"), a substantial VaxGen Inc. VXGN shareholder, today announced that it agrees entirely with the newly published recommendations by RiskMetrics Group/ISS Governance Services....
MedCap Urges Vote Against Proposed VaxGen Merger With Raven biotechnologies
Stock Price Decline of 40% in the Past 45 Days Shows No "Momentum" for Proposed Raven Transaction; Current Balance Sheet Working Capital is $2.01 Per Share SAN FRANCISCO -- MedCap Management & Research LLC and its affiliates ("MedCap"), a substantial VaxGen Inc. VXGN shareholder, urge all VaxGen shareholders...
VaxGen Inc. Review in Progress.
M2 PRESSWIRE-17 March 2008-MB Alerts: VaxGen Inc. Review in ProgressC1994-2008 M2 COMMUNICATIONS LTD RDATE:17032008 MaybachFinancial.com is one of the fastest growing independent and unbiased research firms in the world. Investors wanting to know the truth about investing and how...
VaxGen Common Stock Now Quoted on OTC Bulletin Board
Quotation satisfies closing condition to the proposed merger with Raven biotechnologies, inc. SOUTH SAN FRANCISCO, Calif., March 14 /PRNewswire-FirstCall/ -- VaxGen, Inc. (BULLETIN BOARD: VXGN) , a biopharmaceutical company, announced that its stock is now quoted on the OTC Bulletin Board. Punk, Ziegel and Company...
VaxGen Reports Financial Update
SOUTH SAN FRANCISCO, Calif., March 6 /PRNewswire-FirstCall/ -- VaxGen Inc. (Pink Sheets: VXGN), a biopharmaceutical company, today reported its year end financial results and more recent cash balance, with a view to ensuring that stockholders have the most current financial information ahead of voting on the company's proposed merger...
VVTV, ALMY, AVAL, EFGU, VXGN, VCTY Have Also Been Removed From Naked Short List Today.
M2 PRESSWIRE-3 March 2008-BUYINS.NET: VVTV, ALMY, AVAL, EFGU, VXGN, VCTY Have Also Been Removed From Naked Short List TodayC1994-2008 M2 COMMUNICATIONS LTD RDATE:03032008 BUYINS.NET, www.buyins.net, announced today that these select companies have been removed from the NASDAQ, AMEX and...
Momentum Continues for Merger of VaxGen and Raven
VaxGen Management and Board Encourage Stockholders to Vote in Favor of the Merger SOUTH SAN FRANCISCO, Calif., Feb. 21 /PRNewswire-FirstCall/ -- Dear VaxGen Stockholder, As you are aware, the Boards of Directors of VaxGen and Raven biotechnologies have unanimously approved the merger of the two...
AITX, VXGN Have Also Been Added To Naked Short List Today.
M2 PRESSWIRE-15 February 2008-BUYINS.NET: AITX, VXGN Have Also Been Added To Naked Short List TodayC1994-2008 M2 COMMUNICATIONS LTD RDATE:15022008 BUYINS.NET, www.buyins.net, announced today that these select companies have been added to the NASDAQ, AMEX and NYSE naked short threshold...
Emerging Stock Report for Wednesday, February 06, 2008: CAAH Analyst Rating!
TheSUBWAY.com announces the following stocks toits Action List: China America Holdings, Inc. (OTCBB: CAAH), JDS UniphaseCorp. (NASDAQ: JDSU), iVoice Technology, Inc. (OTCBB: IVOT), VaxGen, Inc.(PINKSHEETS: VXGN). Visit TheSUBWAY's Small Cap Investor Forum Here: http://www.thesubway.com/small-cap-forum/ to discuss our daily stock picksthroughout the trading day! China America Holdings, Inc. (OTCBB:...
Stock Market Alerts Speak with Other Investors about STHG TheSUBWAYs New Small Cap Investor Forum: FEED Announces New Vice President of Technology!
M2 PRESSWIRE-22 January 2008-TheSubway.com: Stock Market Alerts Speak with Other Investors about STHG TheSUBWAYs New Small Cap Investor Forum: FEED Announces New Vice President of Technology!C1994-2008 M2 COMMUNICATIONS LTD RDATE:22012008 Visit TheSUBWAY's Small Cap Investor Forum Here:...
MedCap Opposes VaxGen's Proposed Merger with Raven biotechnologies
Stock Has Declined 46% Since November 12, 2007 Announcement of Proposed Merger SAN FRANCISCO -- MedCap Management & Research LLC ("MedCap"), a substantial VaxGen Inc. VXGN shareholder, in a letter to VaxGen's board of directors, has informed VaxGen that MedCap opposes VaxGen's proposed merger with...
MPM BioEquities Demands VaxGen Drop Merger Plan with Raven
$2.30 a Share in Cash is Not Reflected in Value of Deal at $0.42 Current Value; 63% Stock Decline Since Merger Announced SOUTH SAN FRANCISCO, Calif. -- MPM BioEquities Advisers ("MPM"), a VaxGen Inc. (Pink Sheets:VXGN) shareholder, in a letter to VaxGen's CEO...
Sitrick And Co. Opens San Francisco Office
SAN FRANCISCO -- Sitrick And Company, whose clients include Fortune 100 companies and high-profile individuals such as Patricia Dunn, Roy Disney, Ron Burkle, and Thomas H. Lee, has opened an office in San Francisco. The office is headed by Lance Ignon, a former business and...
- Next »
- page 1 of 1
- « Previous
- Incorporated: 1995
- CEO: Mr. James P. Panek
Vaxgen is a biopharmaceutical company focused on the development, manufacture and commercialization of biologic products for the prevention and treatment of human infectious disease. Co. is developing vaccines against inhalation anthrax and smallpox for the purpose of biodefense. In collaboration with the Chemo-Sero-Therapeutic Research Institute of Japan ("Kaketsuken"), Co. is also developing, for use in the United States and internationally, LC16m8, an attenuated smallpox vaccine candidate. Co. is developing rPA102, a recombinant Protective Antigen anthrax vaccine candidate, with the assistance of funding from its NIAID Contracts.
Key Competitors
Vaxgen Inc. Company Info
Board of Directors
Mr. Paul De Stefano
Mr. James P. Panek
Mr. Franklin M. Berger CFA
Mr. Kevin L. Reilly
Dr. Lori F. Rafield Ph.D.
Contact Information
349 Oyster Point Boulevard
South San Francisco, CA
650 624-1000
NAICS Code
Pharmaceutical Preparation Manufacturing: 325412
